INNOVENTRIC | $28,500,000 | (Oct 30, 2024)
HOMEE, Inc. | $12,000,000 | (Oct 30, 2024)
Pathos | $62,000,000 | (Oct 30, 2024)
Certified by Founder
Lodge
Nomic Bio
start up
Canada
- Montreal, QC
- 18/09/2024
- Series B
- $42,000,000
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
- Industry Biotechnology Research
- Website https://nomic.bio/
- LinkedIn https://www.linkedin.com/company/nomicbio/
Matia | $10,500,000 | (Oct 30, 2024)
Infinite Machine | $9,300,000 | (Oct 30, 2024)
Table22 | $11,000,000 | (Oct 30, 2024)
Latii | $5,000,000 | (Oct 30, 2024)
CredibleMind | $7,500,000 | (Oct 30, 2024)
Billd | $17,500,000 | (Oct 30, 2024)
Andium | $21,700,000 | (Oct 30, 2024)
RiPSIM Technologies | $5,000,000 | (Oct 30, 2024)
HomeBoost | $4,000,000 | (Oct 30, 2024)